ADE LLC’s Medtronic MDT Stock Holding History

ADE LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-140	Closed	-$18K	–	168
2021 Q3	$18K	Sell	140 -690	-83%	-$89.3K	0.02%	176
2021 Q2	$103K	Hold	830	–	–	0.09%	98
2021 Q1	$98K	Sell	830 -950	-53%	-$111K	0.1%	95
2020 Q4	$209K	Buy	+1,780	New	+$196K	0.17%	74

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ADE LLC's MDT Position: Q4 2021 in Review

ADE LLC sold out of Medtronic (MDT) in Q4 2021, closing a stake of 140 shares — an estimated $18K sold.

ADE LLC first reported a position in MDT in Q4 2020 and held it in 4 quarters. The position peaked at $209K in Q4 2020. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

ADE LLC reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
ADE LLC sold 140 Medtronic shares in Q4 2021, an estimated $18K.
ADE LLC first reported a position in Medtronic in Q4 2020 and held it in 4 quarters.
ADE LLC's Medtronic position peaked at $209K in Q4 2020.
2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on ADE LLC's 13F filing for Q4 2021, filed 14 Feb 2022.